Sarah D Lichenstein1, Corey Roos2, Robert Kohler2, Brian Kiluk2, Kathleen M Carroll2, Patrick D Worhunsky2, Katie Witkiewitz3, Sarah W Yip4. 1. Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut. Electronic address: sarah.lichenstein@yale.edu. 2. Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut. 3. Department of Psychology, University of New Mexico, Albuquerque, New Mexico. 4. Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut; Child Study Center, Yale School of Medicine, New Haven, Connecticut. Electronic address: sarah.yip@yale.edu.
Abstract
BACKGROUND: Regardless of the precise mechanism, all neurodevelopmental models of risk assume that, at the population level, there exist subgroups of individuals that share similar patterns of neural function and development-and that these subgroups somehow relate to psychiatric risk. However, the existence of multiple neurodevelopmental subgroups at the population level has not been assessed previously. METHODS: In the current study, cross-validated latent profile analysis was used to test for the presence of empirically derived, brain-based developmental subgroups using functional magnetic resonance imaging data from 6758 individuals (49.4% female; mean age = 9.94 years) in the Adolescent Brain and Cognitive Development (ABCD) study wave 1 release. Data were randomly split into training and testing samples. RESULTS: Analyses in the training sample (n = 3379) identified a seven-profile solution (entropy = 0.880) that was replicated in the held-out testing data (n = 3379, entropy = 0.890). Identified subgroups included a moderate group (66.8%), high reward (4.3%) and low reward (4.0%) groups, high inhibition (9.8%) and low inhibition (6.7%) groups, and high emotion regulation (4.0%) and low emotion regulation (4.3%) groups. Relative to the moderate group, other subgroups were characterized by more males (χ2 = 24.10, p = .0005), higher proportions of individuals from lower-income households (χ2 = 122.17, p < .0001), poorer cognitive performance (ps < .0001), more screen time (F = 6.80, p < .0001), heightened impulsivity (ps < .006), and higher rates of neurodevelopmental disorders (χ2 = 26.20, p = .0002). CONCLUSIONS: These data demonstrate the existence of multiple, distinct neurodevelopmental subgroups at the population level. They indicate that these empirically derived, brain-based developmental profiles relate to differences in clinical features, even at a young age, and prior to the peak period of risk for the development of psychopathology.
BACKGROUND: Regardless of the precise mechanism, all neurodevelopmental models of risk assume that, at the population level, there exist subgroups of individuals that share similar patterns of neural function and development-and that these subgroups somehow relate to psychiatric risk. However, the existence of multiple neurodevelopmental subgroups at the population level has not been assessed previously. METHODS: In the current study, cross-validated latent profile analysis was used to test for the presence of empirically derived, brain-based developmental subgroups using functional magnetic resonance imaging data from 6758 individuals (49.4% female; mean age = 9.94 years) in the Adolescent Brain and Cognitive Development (ABCD) study wave 1 release. Data were randomly split into training and testing samples. RESULTS: Analyses in the training sample (n = 3379) identified a seven-profile solution (entropy = 0.880) that was replicated in the held-out testing data (n = 3379, entropy = 0.890). Identified subgroups included a moderate group (66.8%), high reward (4.3%) and low reward (4.0%) groups, high inhibition (9.8%) and low inhibition (6.7%) groups, and high emotion regulation (4.0%) and low emotion regulation (4.3%) groups. Relative to the moderate group, other subgroups were characterized by more males (χ2 = 24.10, p = .0005), higher proportions of individuals from lower-income households (χ2 = 122.17, p < .0001), poorer cognitive performance (ps < .0001), more screen time (F = 6.80, p < .0001), heightened impulsivity (ps < .006), and higher rates of neurodevelopmental disorders (χ2 = 26.20, p = .0002). CONCLUSIONS: These data demonstrate the existence of multiple, distinct neurodevelopmental subgroups at the population level. They indicate that these empirically derived, brain-based developmental profiles relate to differences in clinical features, even at a young age, and prior to the peak period of risk for the development of psychopathology.
Authors: Alexandra M Rodman; Jessica L Jenness; David G Weissman; Daniel S Pine; Katie A McLaughlin Journal: Biol Psychiatry Date: 2019-05-10 Impact factor: 13.382
Authors: Natasha Duell; Laurence Steinberg; Jason Chein; Suha M Al-Hassan; Dario Bacchini; Chang Lei; Nandita Chaudhary; Laura Di Giunta; Kenneth A Dodge; Kostas A Fanti; Jennifer E Lansford; Patrick S Malone; Paul Oburu; Concetta Pastorelli; Ann T Skinner; Emma Sorbring; Sombat Tapanya; Liliana Maria Uribe Tirado; Liane Peña Alampay Journal: Dev Psychol Date: 2016-09-05
Authors: Donald J Hagler; SeanN Hatton; M Daniela Cornejo; Carolina Makowski; Damien A Fair; Anthony Steven Dick; Matthew T Sutherland; B J Casey; Deanna M Barch; Michael P Harms; Richard Watts; James M Bjork; Hugh P Garavan; Laura Hilmer; Christopher J Pung; Chelsea S Sicat; Joshua Kuperman; Hauke Bartsch; Feng Xue; Mary M Heitzeg; Angela R Laird; Thanh T Trinh; Raul Gonzalez; Susan F Tapert; Michael C Riedel; Lindsay M Squeglia; Luke W Hyde; Monica D Rosenberg; Eric A Earl; Katia D Howlett; Fiona C Baker; Mary Soules; Jazmin Diaz; Octavio Ruiz de Leon; Wesley K Thompson; Michael C Neale; Megan Herting; Elizabeth R Sowell; Ruben P Alvarez; Samuel W Hawes; Mariana Sanchez; Jerzy Bodurka; Florence J Breslin; Amanda Sheffield Morris; Martin P Paulus; W Kyle Simmons; Jonathan R Polimeni; Andre van der Kouwe; Andrew S Nencka; Kevin M Gray; Carlo Pierpaoli; John A Matochik; Antonio Noronha; Will M Aklin; Kevin Conway; Meyer Glantz; Elizabeth Hoffman; Roger Little; Marsha Lopez; Vani Pariyadath; Susan Rb Weiss; Dana L Wolff-Hughes; Rebecca DelCarmen-Wiggins; Sarah W Feldstein Ewing; Oscar Miranda-Dominguez; Bonnie J Nagel; Anders J Perrone; Darrick T Sturgeon; Aimee Goldstone; Adolf Pfefferbaum; Kilian M Pohl; Devin Prouty; Kristina Uban; Susan Y Bookheimer; Mirella Dapretto; Adriana Galvan; Kara Bagot; Jay Giedd; M Alejandra Infante; Joanna Jacobus; Kevin Patrick; Paul D Shilling; Rahul Desikan; Yi Li; Leo Sugrue; Marie T Banich; Naomi Friedman; John K Hewitt; Christian Hopfer; Joseph Sakai; Jody Tanabe; Linda B Cottler; Sara Jo Nixon; Linda Chang; Christine Cloak; Thomas Ernst; Gloria Reeves; David N Kennedy; Steve Heeringa; Scott Peltier; John Schulenberg; Chandra Sripada; Robert A Zucker; William G Iacono; Monica Luciana; Finnegan J Calabro; Duncan B Clark; David A Lewis; Beatriz Luna; Claudiu Schirda; Tufikameni Brima; John J Foxe; Edward G Freedman; Daniel W Mruzek; Michael J Mason; Rebekah Huber; Erin McGlade; Andrew Prescot; Perry F Renshaw; Deborah A Yurgelun-Todd; Nicholas A Allgaier; Julie A Dumas; Masha Ivanova; Alexandra Potter; Paul Florsheim; Christine Larson; Krista Lisdahl; Michael E Charness; Bernard Fuemmeler; John M Hettema; Hermine H Maes; Joel Steinberg; Andrey P Anokhin; Paul Glaser; Andrew C Heath; Pamela A Madden; Arielle Baskin-Sommers; R Todd Constable; Steven J Grant; Gayathri J Dowling; Sandra A Brown; Terry L Jernigan; Anders M Dale Journal: Neuroimage Date: 2019-08-12 Impact factor: 7.400
Authors: Antonius J VAN Rooij; Daria J Kuss; Mark D Griffiths; Gillian W Shorter; M Tim Schoenmakers; Dike VAN DE Mheen Journal: J Behav Addict Date: 2014-08-26 Impact factor: 6.756
Authors: H Garavan; H Bartsch; K Conway; A Decastro; R Z Goldstein; S Heeringa; T Jernigan; A Potter; W Thompson; D Zahs Journal: Dev Cogn Neurosci Date: 2018-04-16 Impact factor: 6.464
Authors: Kathryn L Mills; Anne-Lise Goddings; Liv S Clasen; Jay N Giedd; Sarah-Jayne Blakemore Journal: Dev Neurosci Date: 2014-06-27 Impact factor: 2.984